IISc’s vax has potential to fight Indian variants, but it has a funding problem ByHemanth CSHemanth CS / Updated: May 3, 2021, 06:00 IST It’s other key advantage: It can be stored at room temperature after freeze drying With the chorus for more options for covid vaccines getting louder and louder, and foreign vaccines waiting for approval to be allowed in India, another local vaccine is under development. And this one is being developed in Bengaluru. A recombinant subunit vaccine for SARS-CoV-2 which is being developed by the Indian Institute of Science (IISc), has over the last few months been able to create several highly immunogenic thermotolerant versions, said researchers associated with the project.